Pyng Medical Corp.

Pyng Medical Corp.

September 26, 2007 10:27 ET

Pyng Medical Lands Canadian Forces

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 26, 2007) - Pyng Medical Corp. (TSX VENTURE:PYT) is pleased to announce the Canadian Forces are now actively using the FAST1™ Intraosseous Infusion System in the field in Afghanistan. Pyng's Canadian distributor Canadian Tactical & Operational Medical Solutions(CTOMS) is working closely with the Department of National Defense to provide training and distribution.

"We are pleased to be able to contribute to saving the lives of Canadian Forces with the FAST1™," said David Christie, President and Chief Executive Officer. "While our product has been in use by the US Military for some time, adoption of the technology by the Canadian Forces reinforces the importance and need of intraosseous infusion in combat situations."

"CTOMS began teaching Canadian Forces Med Techs the use of the FAST1™ this year. The FAST1™ is ideal for use in combat environments for numerous reasons," said Chris Kopp, Chief Executive Officer of CTOMS. "Given the environment, its simplicity and safety make it the ideal choice for the Canadian Military."

Safe Harbour Statement; Forward-Looking Statements: This release may contain forward-looking statements based on management's expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "projects", "indicates", and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions, including inflation, interest and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures and alliances; cost of raw material, research and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • Pyng Medical Corp.
    David Christie
    Toll Free: 1-800-349-7964